{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T03:46:48Z","timestamp":1773460008607,"version":"3.50.1"},"publisher-location":"Chichester, UK","reference-count":47,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd003458.pub3","type":"reference-entry","created":{"date-parts":[[2008,4,21]],"date-time":"2008-04-21T05:56:47Z","timestamp":1208757407000},"source":"Crossref","is-referenced-by-count":10,"title":["Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V)"],"prefix":"10.1002","author":[{"given":"Rosaline","family":"Quinlivan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J","family":"Beynon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Martinuzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,4,23]]},"reference":[{"key":"10.1002\/14651858.CD003458.pub3-BIB1|cit1","series-title":"Muscle & Nerve","article-title":"McArdle's Disease: molecular genetics, clinical heterogeneity and a therapeutic trial","author":"Beynon","year":"1998"},{"issue":"6","key":"10.1002\/14651858.CD003458.pub3-BIB2|cit2","first-page":"748","article-title":"Depot-glucagon in the treatment of McArdle's disease","volume":"15","author":"Day","year":"1985","journal-title":"Australian and New Zealand Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD003458.pub3-BIB3|cit3","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1001\/archneur.1990.00530040023014","article-title":"Are high-protein diets effective in McArdle's Disease","volume":"47","author":"Kushner","year":"1990","journal-title":"Archives of Neurology"},{"issue":"7","key":"10.1002\/14651858.CD003458.pub3-BIB4|cit4","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/mus.880090710","article-title":"A double-blind crossover study of verapamil in exertional muscle pain","volume":"9","author":"Lane","year":"1986","journal-title":"Muscle & Nerve"},{"issue":"5","key":"10.1002\/14651858.CD003458.pub3-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1212\/WNL.51.5.1456","article-title":"Oral branched chain amino acids do not improve exercise capacity in McArdle's disease","volume":"51","author":"MacLean","year":"1998","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD003458.pub3-BIB6|cit6","first-page":"64","article-title":"Chronic therapy for McArdle disease: the randomized controlled trial with ACE inhibitor","volume":"26","author":"A","year":"2007","journal-title":"Acta Myologica"},{"issue":"1-2","key":"10.1002\/14651858.CD003458.pub3-BIB7|cit7","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/0022-510X(90)90020-N","article-title":"Dantrolene sodium does influence the second wind phenomenon in McArdle's disease. Electrophysioloical evidence during exercise in a double-blind placebo-controlled, cross-over study in 5 patients","volume":"100","author":"Poels","year":"1990","journal-title":"Journal of the Neurological Sciences"},{"issue":"1-2","key":"10.1002\/14651858.CD003458.pub3-BIB8|cit8","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0022-510X(95)00320-2","article-title":"A double-blind, placebo controlled, crossover trial of D-ribose in McArdle's disease","volume":"136","author":"Steele","year":"1996","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1002\/14651858.CD003458.pub3-BIB9|cit9","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1056\/NEJMoa031836","article-title":"The effect of oral sucrose on exercise tolerance in patients with McArdle's disease","volume":"349","author":"Vissing","year":"2003","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD003458.pub3-BIB10|cit10","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.nmd.2007.03.001","article-title":"144th ENMC International Workshop: Outcome Measures in McArdle Disease, 29 September-1 November 2006, Naarden, The Netherlands","volume":"17","author":"Vissing","year":"2007","journal-title":"Neuromuscular Disorders"},{"issue":"7","key":"10.1002\/14651858.CD003458.pub3-BIB11|cit11","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1001\/archneur.57.7.956","article-title":"Creatine therapy in myophosphorylase deficiency (McArdle's disease) A placebo controlled crossover trial","volume":"57","author":"Vorgerd","year":"2000","journal-title":"Archives of Neurology"},{"issue":"1","key":"10.1002\/14651858.CD003458.pub3-BIB12|cit12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/archneur.59.1.97","article-title":"Effect of high-dose creatine therapy on symptoms of exercise intolerance in McArdle's disease: double-blind, placebo-controlled crossover study","volume":"59","author":"Vorgerd","year":"2002","journal-title":"Archives of Neurology"},{"issue":"2","key":"10.1002\/14651858.CD003458.pub3-BIB13|cit13","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/ana.20565","article-title":"Treatment of glycogenosis type V with ketogenic diet","volume":"58","author":"Busch","year":"2005","journal-title":"Annals of Neurology"},{"issue":"9","key":"10.1002\/14651858.CD003458.pub3-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1001\/archneur.59.9.1395","article-title":"Spontaneous \"second wind\" and glucose-induced \"second wind\" in McArdle disease","volume":"59","author":"Haller","year":"2002","journal-title":"Archives of Neurology"},{"issue":"6","key":"10.1002\/14651858.CD003458.pub3-BIB15|cit15","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1600-0404.1990.tb01007.x","article-title":"Improved energy kinetics following high protein diet in McArdle's syndrome. A 31P magnetic resonance spectroscopy study","volume":"81","author":"Jensen","year":"1990","journal-title":"Acta Neurologica Scandinavica"},{"issue":"11","key":"10.1002\/14651858.CD003458.pub3-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1212\/WNL.34.11.1471","article-title":"Metabolic basis of improved exercise tolerance: Muscle phosphorylase deficiency after glucagon administration","volume":"34","author":"Kono","year":"1984","journal-title":"Neurology"},{"issue":"6","key":"10.1002\/14651858.CD003458.pub3-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1152\/jappl.1985.59.6.1991","article-title":"Muscle fatigue in McArdle's disease studied by 31P-NMR: effect of glucose infusion","volume":"59","author":"Lewis","year":"1985","journal-title":"Journal of Applied Physiology"},{"issue":"7","key":"10.1002\/14651858.CD003458.pub3-BIB18|cit18","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/mus.880070706","article-title":"A comparative study on glucagon effect between McArdle disease and Tarui disease","volume":"7","author":"Mineo","year":"1984","journal-title":"Muscle & Nerve"},{"issue":"2","key":"10.1002\/14651858.CD003458.pub3-BIB19|cit19","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/003693300304800206","article-title":"Exercise to exhaustion in the second-wind phase of exercise in case of McArdle's disease with and without creatine supplementation","volume":"48","author":"O'Reilly","year":"2003","journal-title":"Scottish Medical Journal"},{"issue":"3-4","key":"10.1002\/14651858.CD003458.pub3-BIB20|cit20","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0960-8966(98)00004-2","article-title":"Effect of vitamin B6 supplementation in McArdle's disease: a strategic case study","volume":"8","author":"Phoenix","year":"1998","journal-title":"Neuromuscular Disorders"},{"issue":"2","key":"10.1002\/14651858.CD003458.pub3-BIB21|cit21","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1212\/01.wnl.0000194212.31318.fc","article-title":"Gentamicin treatment in McArdle disease: Failure to correct myophosphorylase deficiency","volume":"66","author":"Schroers","year":"2006","journal-title":"Neurology"},{"issue":"6","key":"10.1002\/14651858.CD003458.pub3-BIB22|cit22","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1056\/NEJM198502073120607","article-title":"Myopathy in McArdle's syndrome: improvement with a high protein diet","volume":"312","author":"Slonim","year":"1985","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD003458.pub3-BIB23|cit23","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00000441-197503000-00008","article-title":"McArdle's syndrome: the reaction to a fat rich diet","volume":"269","author":"Viskoper","year":"1975","journal-title":"American Journal of Medical Sciences"},{"issue":"2","key":"10.1002\/14651858.CD003458.pub3-BIB24|cit24","first-page":"61","article-title":"Treatment of glycogenosys type V (McArdle disease) with creatine and ketogenic diet with clinical scores and with 31P-MRS on working leg muscle","volume":"26","author":"Vorgerd","year":"2007","journal-title":"Acta Myologica"},{"issue":"2","key":"10.1002\/14651858.CD003458.pub3-BIB25|cit25","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/BF01666823","article-title":"McCardle's disease: successful symptomatic therapy by high dose oral administration of ribose","volume":"69","author":"Wagner","year":"1991","journal-title":"Klinische Wochenschrift"},{"issue":"1","key":"10.1002\/14651858.CD003458.pub3-BIB26|cit26","first-page":"53","article-title":"McArdle disease: molecular genetic update","volume":"26","author":"Andreu","year":"2007","journal-title":"Acta Myologica"},{"issue":"4","key":"10.1002\/14651858.CD003458.pub3-BIB27|cit27","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1172\/JCI7866","article-title":"Aminoglycodise antibiotics restore dystrophin function to skeletal muscles of mdx mice","volume":"104","author":"Barton-Davis","year":"1999","journal-title":"The Journal of Clinical Investigation"},{"issue":"8","key":"10.1002\/14651858.CD003458.pub3-BIB28|cit28","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1093\/hmg\/2.8.1291","article-title":"McArdle's disease: a nonsense mutation in exon 1 of the muscle glycogen phosphorylase gene explains some but not all cases","volume":"2","author":"Bartram","year":"1993","journal-title":"Human Molecular Genetics"},{"issue":"8272","key":"10.1002\/14651858.CD003458.pub3-BIB29|cit29","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0140-6736(82)91767-6","article-title":"Beneficial effects of Dantrolene sodium in exercise-induced muscle pains: calcium mediated?","volume":"1","author":"Bertorini","year":"1982","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003458.pub3-BIB30|cit30","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1002\/mus.880181406","article-title":"McArdle's disease: molecular genetics and metabolic consequences of the phenotype","volume":"3","author":"Beynon","year":"1995","journal-title":"Muscle & Nerve"},{"key":"10.1002\/14651858.CD003458.pub3-BIB31|cit31","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1249\/00005768-198205000-00012","article-title":"Psychophysical basis for perceived exertion","volume":"14","author":"Borg","year":"1982","journal-title":"Medicine and Science in Sports and Exercise"},{"issue":"6","key":"10.1002\/14651858.CD003458.pub3-BIB32|cit32","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/(SICI)1097-4598(199606)19:6<764::AID-MUS12>3.0.CO;2-L","article-title":"Impairment of muscle mitochondrial oxidative metabolism in McArdle's disease","volume":"19","author":"Stefano","year":"1996","journal-title":"Muscle & Nerve"},{"key":"10.1002\/14651858.CD003458.pub3-BIB33|cit33","article-title":"The I allele of the ACE gene is associated with improvement in exercise capacity in women with McArdle disease","volume":"Epub ahead of p","author":"Gomez-Gallego","journal-title":"British Journal of Sports Medicine"},{"issue":"2","key":"10.1002\/14651858.CD003458.pub3-BIB34|cit34","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0002-9343(83)90614-9","article-title":"Low levels of muscle pyridoxine in McArdle's syndrome","volume":"74","author":"Haller","year":"1983","journal-title":"American Journal of Medicine"},{"key":"10.1002\/14651858.CD003458.pub3-BIB35|cit35","first-page":"1355","article-title":"Molecular diagnosis of McArdle's disease: revised genomic structure of the phosphorylase gene and identification of a novel mutation","volume":"43","author":"Kubisch","year":"1998","journal-title":"Human Mutation"},{"issue":"12","key":"10.1002\/14651858.CD003458.pub3-BIB36|cit36","first-page":"1355","article-title":"Brief periods of occlusion and re-perfusion increase skeletal muscle force output in humans","volume":"43","author":"Libonati","year":"1998","journal-title":"Cardiologia"},{"issue":"8","key":"10.1002\/14651858.CD003458.pub3-BIB37|cit37","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.nmd.2007.04.006","article-title":"The 577X allele of the ACTN3 gene is associated with improved exercise capacity in women with McArdle's disease","volume":"17","author":"Lucia","year":"2007","journal-title":"Neuromuscular Disorders"},{"issue":"4","key":"10.1002\/14651858.CD003458.pub3-BIB38|cit38","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/ana.10499","article-title":"Phenotype modulators in myophosphorylase deficiency","volume":"53","author":"Martinuzzi","year":"2003","journal-title":"Annals of Neurology"},{"key":"10.1002\/14651858.CD003458.pub3-BIB39|cit39","first-page":"13","article-title":"Myopathy due to a defect in muscle glycogen breakdown","volume":"10","author":"McArdle","year":"1951","journal-title":"Clinical Science"},{"key":"10.1002\/14651858.CD003458.pub3-BIB40|cit40","first-page":"18","article-title":"A functional disorder of muscle associated with the absence of phosphorylase","volume":"3","author":"Mommaerts","year":"1959","journal-title":"Proceedings of the National Academy of Science USA"},{"key":"10.1002\/14651858.CD003458.pub3-BIB41|cit41","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/0002-9343(61)90075-4","article-title":"A metabolic myopathy due to absence of muscle phosphorylase","volume":"30","author":"Pearson","year":"1961","journal-title":"The American Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD003458.pub3-BIB42|cit42","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.neulet.2007.06.025","article-title":"Genotype modulators of clinical severity in McArdle disease","volume":"422","author":"Rubio","year":"2007","journal-title":"Neuroscience Letters"},{"issue":"1","key":"10.1002\/14651858.CD003458.pub3-BIB43|cit43","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1212\/WNL.50.1.6","article-title":"Why do patients with McArdle's disease have decreased exercise capacity?","volume":"50","author":"Ruff","year":"1998","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD003458.pub3-BIB44|cit44","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1172\/JCI103983","article-title":"Chronic progressive myopathy with myoglobinuria: demonstration of a glycogenolytic defect in muscle","volume":"108","author":"Schmidt","year":"1959","journal-title":"Journal of Clinical Investigation"},{"key":"10.1002\/14651858.CD003458.pub3-BIB45|cit45","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1002\/(SICI)1097-4598(199712)20:12<1502::AID-MUS4>3.0.CO;2-C","article-title":"A randomised controlled trial of creatine monohydrate in patients with mitochondrial cytopathies","volume":"20","author":"Tarnopolsky","year":"1997","journal-title":"Muscle & Nerve"},{"key":"10.1002\/14651858.CD003458.pub3-BIB46|cit46","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1152\/jappl.1997.83.6.2055","article-title":"Long term creatine intake is beneficial to muscle performance during resistance training","volume":"83","author":"Vandenberghe","year":"1997","journal-title":"Journal of Applied Physiology"},{"key":"10.1002\/14651858.CD003458.pub3-BIB47|cit47","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1172\/JCI555","article-title":"Sympathetic activation in exercise is not dependent on muscle acidosis. Direct evidence from studies in metabolic myopathies","volume":"108","author":"Vissing","year":"1998","journal-title":"Journal of Clinical Investigation"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD003458.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T17:20:59Z","timestamp":1628529659000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD003458.pub3"}},"subtitle":[],"editor":[{"given":"Rosaline","family":"Quinlivan","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2008,4,23]]},"references-count":47,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003458.pub3","relation":{},"subject":[],"published":{"date-parts":[[2008,4,23]]}}}